NK cells can co-express inhibitory and activating killer Ig-like receptors (KIR) recognizing the same HLA class I ligand. We present evidence from experiments with NK cells expressing both activating (KIR2DS2) and inhibitory (KIR2DL2 and KIR2DL3) receptors that the activating KIR can function without apparent interference from the inhibitory KIR. These studies used CD158b mAb that is equally reactive with KIR2DS2, KIR2DL2 and KIR2DL3. First, we show using plastic-immobilized CD158b mAb that the activating KIR2DS2 is stimulated, resulting in NK cell division and degranulation. Second, we show using soluble CD158b mAb and FcRII ⍣ P815 cells that high concentrations of CD158b mAb trigger the inhibitory KIR, whereas low concentrations stimulate the activating KIR2DS2 resulting in NK cell division and cytolysis. These results demonstrate that the activating KIR2DS2 can function on cells co-expressing the inhibitory KIR2DL2 and/or KIR2DL3, indicating the potential for independent function of activating KIR with natural ligand.
Introduction

NK cells express receptors for MHC class I that either inhibit
revealed that 38 clones co-expressed inhibitory and activating receptors for the same MHC class I ligand (4) . or activate NK cell effector function (recently reviewed in 1,2). There are two families of receptors, the killer Ig-like receptors
In this study, we assess the functional activity of KIR on NK cells that co-express the activating KIR2DS2 (two Ig-like (KIR) that recognize specific groups of HLA-A, -B, -C alleles, and the C-type lectin receptors (CD94/NKG2 family) that domains, short cytoplasmic tail, p50) and the inhibitory KIR2DL2 and KIR2DL3 (two Ig-like domains, long cytoplasmic recognize HLA -A, -B, -C indirectly through recognition of HLA-E that is surface expressed when it binds the leader tail, p58). These KIR recognize the polymorphism S77, N80 in HLA-Cw1, 3, 7 and 8. The extracellular domain of KIR2DS2 sequences of certain HLA class I molecules. The inhibitory receptors of both receptor families are characterized by the differs from KIR2DL2 and KIR2DL3 by only 4 and 3 amino acids respectively (5) . These three KIR are collectively termed presence of immunoreceptor tyrosine-based inhibitory motifs (ITIM) in their cytoplasmic tail. The activating receptors of CD158b (6) and CD158b mAb cannot distinguish these three receptors. We have asked the question under what conditions both families are characterized by a charged residue in the transmembrane domain allowing association with a 12-kDa NK cells co-expressing activating and inhibitory KIR to the same HLA class I ligand are stimulated through the activating membrane adaptor molecule DAP12/KARAP that contains an immunoreceptor tyrosine-based activation motif (ITAM).
receptor. We show in two different culture systems, using either plastic-immobilized CD158b mAb or low concentrations Typically, individual NK cells express inhibitory and/or activating receptors of both the KIR and CD94/NKG2 receptor of soluble CD158b mAb and FcRII ϩ P815 target cells to cross-link the receptors, that the activating KIR2DS2 can be families. With respect to the KIR, it was reported earlier that activating and inhibitory receptors on NK cell clones have stimulated without interference from the inhibitory KIR2DL2 and/or KIR2DL3. The potential for independent functioning different MHC class I specificities (3) , but more recently a RT-PCR analysis of Ͼ100 NK cell clones from one individual of activating and inhibitory KIR with natural ligand, that is dependent on the density of class I MHC on the target cell, in these cultures were entirely NK cells (CD3 -CD56 ϩ CD16 ϩ CD94 ϩ ). NK cells were subcultured from day 8 as is suggested from this study.
required, maintaining cell concentrations at 0.5ϫ10 6 tation of surface biotinylated NK cells and analysis by SDS-(CD94, IgM) and WV6 (CD158b, IgM) prepared in our PAGE using procedures described previously (10), except laboratory. IgG mAb were purified by Protein A-Sepharose that the CD158b mAb (WV6, IgM) used for immunoprecipi-CL-4B chromatography (Pharmacia Biotech, Boronia, Victoria, tation was bound to anti-mouse IgM (µ chain-specific) agarose Australia) using procedures described by the manufacturer.
beads (Sigma, St. Louis, MO; cat. no. A-4540) and the gels IgM mAb were purified by precipitation following dialysis were run under reducing conditions using 0.1 M dithiothreitol. against water. FITC-conjugated sheep anti-mouse Ig (code Measurement of cytolytic function by 51 Cr release DF) and affinity-purified sheep anti-mouse Ig (code DA) were purchased from AMRAD Pharmacia Biotech. Biotinylated rat Cytotoxic activity of NK cells was measured in a 4-h 51 Cranti-mouse IgM was purchased from PharMingen (San Diego, release assay using 5000 targets at an E:T cell ratio of 1:1 or CA), and FITC-conjugated sheep anti-mouse IgG2a and 2:1 unless otherwise stated, by methods described previously streptavidin-phycoerythrin (PE) from Serotec (Oxford, UK).
(7). Cytotoxicity is expressed as percent specific lysis from Plastic tissue culture wells were coated with mAb as follows.
c.p.m. released into the supernatant from target cells: [(c.p.m. Culture wells were first precoated with affinity-purified antiin test cultures -c.p.m. in control cultures)/(c.p.m. in 1% mouse Ig (50 µl of 10µg/ml in 0.05M Na 2 CO 3 /NaHCO 3 buffer, Triton X-100 lysates -c.p.m. in control cultures)]ϫ100. pH 9.6, overnight at 4°C), washed 4 times with PBS and
For most experiments, percent specific lysis was then then blocked for 30 min with medium containing 5% heatconverted to cytotoxic units (CU) to linearize the data between inactivated FCS (HIFCS) prior to incubation with mAb for 2 h. 30 and 60% lysis (11) according to the formula: CU ϭ -ln Culture wells were then washed 4 times with PBS prior to [(1 -percent specific lysis)/100]ϫ5000. Data were then addition of cells. The mAb concentrations for coating (in the expressed as a percentage of the maximum lysis achieved range 3-10 µg/ml) were 4 times those determined as optimum using saturating concentrations of mAb to activating recepby immunofluorescence staining of cells and flow cytometry.
tors. The dose of mAb to achieve 50% lysis (ED 50 ) was calculated from this data using Biolinx software.
NK cell lines
Measurement of cytolytic function by degranulation Cultured human NK cell lines were established as reported previously (7) . Briefly, peripheral blood mononuclear cells NK cells were cultured in a balanced salt solution containing 10% HIFCS at 400,000 cells per 0.1 ml in flat 96-well tissue were depleted of monocytes by adherence on plastic for 1 h at 37°C, and the T cells and B cells labeled with OKT3 (CD3) culture plates (Linbro, 76-032-05; ICN Biomedicals, Sydney, Australia) that had been precoated with mAb. After 4 h at and FMC63 (CD19) mAb followed by FITC-conjugated antimouse IgG2a. CD158b ϩ NK cells were labeled using WV6 37°C the supernatant was harvested, and granzyme A activity was assayed as N-α-carbobenzoxy-L-Lys-thiobenzyl ester (CD158b) mAb followed by biotinylated anti-mouse IgM and streptavidin-PE. The sorted FITC -, PE ϩ NK cells were cultured (BLT)-esterase activity (12 
Flow cytometry
NK cell binding of mAb was detected by indirect immunofluorescence using FITC-conjugated anti-mouse Ig. Briefly, 2ϫ10 4 NK cells were incubated in 96-well V-bottom plates with mAb at optimum concentrations or at the dilutions indicated for 30 min on ice. The plates were centrifuged and the cells washed 3 times in PBS/5% HIFCS containing 0.1% sodium azide. Optimum concentration of FITC-conjugated sheep anti-mouse Ig was added and following a further 30 min incubation on ice the cells were washed as above prior to fixation in 0.1% (w/v) paraformaldehyde. Immunofluorescence was measured using a FACScan (Becton Dickinson, San Jose, CA) calibrated using CaliBRITE beads (Becton Dickinson). Lymphocytes were gated using forward scatter (size) and side scatter (granularity) parameters. Data were analyzed using PC Lysys software. CFSE-labeled NK cells were analyzed by flow cytometry and the percentage of cells entering cell division was calculated as described previously (7, 8) . In experiments using titrations of soluble mAb and P815 cells, data were expressed as a percentage of the maximum response. The concentration of mAb to achieve 50% (ED 50 ) of this value was calculated using Biolinx software.
Results
CD158b mAb and NK cell lines
The CD158b mAb GL183 (13) and DX27 (14) bind equally to the extracellular domains of the activating KIR2DS2, and the inhibitory KIR2DL2 and KIR2DL3. This was demonstrated using Ba/F3 transfectants expressing individual receptors (14) . The mAb bind similarly to the transfectants (Fig. 1A ) and show similar titration curves (Fig. 1B) . The mAb do not bind to parent Ba/F3 cells (data not shown).
Two CD158b ϩ NK cell lines, A and C, generated from different donors were used in this study (7) . CD158b ( Fig. 2A and D) , functional testing of KIR status by cytotoxic activity using CD158b mAb and FcRII ϩ murine P815 data in Fig. 2 (C) and the immunoprecipitation data in Fig. 3 are qualitative, and do not give a quantitative measure of target cells (Fig. 2B and E) , and the presence of mRNA transcripts for KIR by RT-PCR ( Fig. 2C and F) .
expression of the different receptors on NK cells in line A. For NK cell line C, functional testing (Fig. 2E ) demonstrated For NK cell line A, cross-linking CD158b using mAb and FcRII ϩ P815 cells inhibited CD94 mAb-stimulated NK cell that CD158b is an activating receptor on this cell line. Thus, CD158b mAb stimulated killing of FcRII ϩ P815 cells and there cytotoxicity (Fig. 2B) . There was no stimulation of cytotoxicity in the presence of CD158b mAb alone. These results were was no inhibitory effect of CD158b mAb on CD94 mAb stimulated killing. RT-PCR analysis of KIR mRNA expression obtained with both GL183 and DX27 mAb at concentrations that were optimum for binding to these cells. Although the for NK cell line C revealed the presence of the activating KIR2DS2 but no inhibitory KIR (Fig. 2F) , consistent with the functional read out for CD158b on NK cell line A indicated the presence of an inhibitory receptor, RT-PCR analysis of results in Fig. 2 
(E).
We next undertook cytotoxicity experiments to show that KIR mRNA expression revealed the presence of transcripts for both inhibitory (KIR2DL2 and KIR2DL3) and activating NK cells in line A that express the activating KIR2DS2 must also co-express inhibitory KIR2DL2 and/or KIR2DL3. P815 is (KIR2DS2) receptors on NK cells of this line (Fig. 2C) . Immunoprecipitation of cell surface CD158b from NK cell line killed in the presence of CD158b mAb by NK cells expressing only KIR2DS2 as shown for NK cell line C (Fig. 2E) . The data A (Fig. 3) showed the presence of 58 (inhibitory)-and 50 (activating)-kDa receptors. It should be noted that the RT-PCR in Fig. 4 show that there is no killing of P815 with NK cells
Activation of NK cell division using plastic-bound CD158b mAb
Cross-linking activating receptors such as CD16 using plasticbound mAb stimulates NK cell division and this is readily monitored using cells prelabeled with CFSE (8) , where division is recorded as the sequential decrease in fluorescence as cells divide (15). Because of the sensitivity of this assay we compared NK cell line A (KIR2DS2 ϩ , KIR2DL2 ϩ and/or KIR2DL3 ϩ ) with NK cell line C (KIR2DS2 ϩ ) for their ability to divide when stimulated using plastic-bound CD158b mAb. The results in Fig. 5 compare NK cell line A (Fig. 5A and C) and NK cell line C (Fig. 5B and D) for their ability to divide following stimulation on plastic coated with control CD56 (WV3 or WV5) mAb, CD94 (WV2) mAb (as positive control) and CD158b (GL183 and DX27) mAb. The CFSE profiles are shown in Fig. 5(A and B) and the quantitative data from these profiles showing the percentage of cells that have entered division is shown in Fig. 5 (C and D). Compared to control the CD94 activating receptor ( Fig. 2B and E) . Importantly for Plastic-immobilized CD158b mAb stimulated division of NK cell line C with 50% of cells entering division, but did not stimulate division of an NK cell line lacking CD158b (data not shown).
The ability of NK cell line A to divide when stimulated using plastic-immobilized CD158b mAb was confirmed in a separate series of experiments where CFSE-labeled NK cells were cultured with γ-irradiated MM-170 malignant melanoma cells and rIL-2 on plastic coated with mAb (Fig. 6 ). NK cells from line A are refractory to re-stimulation in secondary and subsequent cultures in the presence of MM-170 cells and rIL-2 unless there is additional stimulation by ligating activating receptors with mAb (8) . In these experiments plastic-bound CD158b mAb provided the additional activation signal for MM-170-stimulated NK cell division with 36% (GL183) and 27% (DX27) of cells entering division compared to 14% in control cultures with plastic-immobilized CD56 mAb. Cultures with plastic-immobilized CD94 mAb were the positive control with 48% of cells stimulated to divide. The percentage of cells stimulated to divide was calculated from CFSE profiles as shown for Fig. 5 . Results are presented as the mean and Plastic-immobilized CD158b mAb was also able to stimulate degranulation of NK cells from line A despite their coexpression of the activating KIR2DS2 and the inhibitory KIR2DL2 and/or KIR2DL3 (Fig. 7A) . Degranulation was from line A in the presence of CD158b mAb even at high E:T cell ratios (10:1), whereas killing of P815 by NK cell line C is assayed by measuring BLT esterase activity released into the culture supernatant after 4 h. Results are presented as the detectable at 100-fold lower E:T cell ratios (0.1:1). This difference does not reflect different cytolytic abilities of the mean OD 405 and SD of triplicate assay points. The results show that degranulation of NK cell line A is stimulated strongly two lines since both NK cell lines killed P815 to similar extents when activated using CD94 mAb ( Fig. 2B and E) , a result by CD94 mAb and also by the CD158b mAb GL183. The CD158b mAb DX27 stimulated only a marginal response in confirmed in other experiments (not shown) over a range of different E:T cell ratios.
this assay. Degranulation of control NK cell line C (KIR2DS2 ϩ ) was stimulated strongly by CD94 mAb and by both CD158b became progressively less. CD94 mAb alone stimulated 82.4% of NK cells to enter division, compared to 9.3% in mAb (Fig. 7B) .
control cultures. The effect of CD158b mAb is presented as Inhibition and activation of NK cell division using soluble a percentage of the CD94 mAb stimulated response. For five CD158b mAb and FcRII ϩ P815 cells different experiments the reciprocal dilution of CD158b mAb giving 50% inhibition of cell division was on average 698 Ϯ FcRII ϩ P815 cells and IgG mAb provide a convenient experimental system to test the function of inhibitory and activating 188 (SEM) of the optimum concentration for binding to these cells. Importantly, we observed in five of eight experiments NK cell receptors in cell division (7) . The results in Fig. 8(A) are of a representative experiment showing cell division by that low concentrations of CD158b mAb were able to stimulate cell division in the absence of CD94 mAb. Results from one NK cell line A stimulated by CD94 mAb and the ability of different concentrations of CD158b mAb to inhibit this of these five experiments is shown in Fig. 8(B) . For the five experiments in which cell division was stimulated by low response. Saturating concentrations of CD158b mAb totally inhibited cell division and at low concentrations inhibition concentrations of CD158b mAb, on average 12.4 Ϯ 3.9% of division was on average 1490 Ϯ 349 of the optimum concentration for binding to these cells.
Inhibition and activation of NK cell cytotoxicity using soluble CD158b mAb and FcRII ϩ P815 cells
The results in Fig. 9(A) are of a representative experiment with NK cell line A showing the dose-dependent inhibition of CD94 mAb-stimulated cytotoxicity by CD158b mAb. Similar results were obtained using either GL183 or DX27 CD158b mAb to inhibit the response and either CD16 or CD94 mAb to stimulate cytotoxicity. For seven different experiments the reciprocal dilution of CD158b mAb required to give 50% inhibition of cytotoxicity was on average 167 Ϯ 17 (SEM) of the optimum concentration for binding to these cells. Consistent with our observation showing that low concentrations of CD158b mAb stimulated proliferation of NK cell line 0.7% in control cultures, a difference of 5-fold. For comparison, CD158b mAb-stimulated killing by NK cell line C (KIR2DS2 ϩ ) also was measurable at low mAb concentrations (Fig. 9C) . In five different experiments, the reciprocal dilution of CD158b mAb required to give 50% maximum response for NK cell line C was on average 1301 Ϯ 133 of the optimum concentration for binding to these cells. These experiments show that CD158b mAb stimulates the activating KIR2DS2 at concentrations lower than that effective for inhibition.
Discussion
This study demonstrates, using CD158b mAb, the potential for the activating KIR2DS2 to function independently of coexpressed inhibitory KIR2DL2 and/or KIR2DL3. For the NK cell line A used in these studies we established by testing cytotoxic activity over a wide range of E:T cell ratios that when the activating KIR2DS2 is expressed so also is KIR2DL2 and/or KIR2DL3. Although inhibitory KIR are dominant in cytotoxicity assays when mAb is used at optimum concentrations, when CD158b mAb is plastic-immobilized a significant proportion of NK cells in line A are stimulated to divide and to degranulate. Re-investigating the ability of soluble CD158b mAb and P815 cells to stimulate cytotoxicity revealed that activating and inhibitory KIR for the same HLA specificity, and that experimentally these receptors can function independently. One hypothesis to explain the significance of co-expression NK cells were stimulated to divide, compared to 5.4 Ϯ 2.0% in control cultures without mAb, a difference of 2.3-fold. For of activating and inhibitory KIR with the same HLA specificity is that the activating receptor maintains activity of the inhibitory comparison, the data in Fig. 8(C) show the effect of different concentrations of CD158b mAb on cell division for NK cells receptor via protein tyrosine kinase activity and phosphorylation of the ITIM (16). An alternative hypothesis, favored by from line C (KIR2052 ϩ ). Comparison of data from six different experiments with NK cell line C showed that the reciprocal our studies, is that the activating and inhibitory KIR have different threshold levels of occupancy for stimulation. dilution of CD158b mAb required for 50% activation of cell Specifically, that the activating KIR2DS2 can function at staining and flow cytometry of the binding of GL183 and CD158b mAb concentrations below that effective for stimula-DX27 mAb to Ba/F3 transfectants that express the different tion of the inhibitory KIR. Importantly, the CD158b mAb used KIR (Fig. 1) . Therefore, the results with CD158b mAb reflect in these studies bind equally to the activating and inhibitory different threshold levels for activation of the KIR2DS2 com-KIR. Vales-Gomez (17) showed by plasmon surface resonance pared to KIR2DL2 and KIR2DL3. measurements that the CD158b (GL183) mAb binds with Activation of KIR2DS2 on NK cells from line A co-expressing similar kinetics to surface immobilized activating KIR2DS2 inhibitory KIR was shown using plastic-immobilized CD158b and inhibitory KIR2DL3 receptors. Winter (5) showed in an mAb, and using low concentrations of soluble CD158b mAb ELISA assay that CD158b (GL183) mAb binds comparably and cross-linking the receptors with FcRII ϩ P815 cells. The to Ig fusion proteins of KIR2DS2, KIR2DL3 and KIR2DL2.
two culture systems were equally effective in stimulating These results agree with our analysis by immunofluorescence cytotoxic activity. By contrast, plastic-immobilized mAb is a more effective stimulus for cell division than is soluble mAb and P815 cells. These observations may reflect differences in the level of sustained signaling afforded by the two culture systems and that are required for the different functional responses. In the case of T cell activation, plastic-immobilized CD3 mAb gave more sustained signaling than cross-linking with soluble mAb, resulting in different activation outcomes (18) . The ability of activating KIR2DS2 to be stimulated without interference from the co-expressed inhibitory KIR using plastic-immobilized CD158b mAb or using low concentrations of soluble mAb with P815 presumably reflects differences in the intracellular signaling pathways for the activating and inhibitory KIR. As reviewed by Tomasello et al. A dimension yet to be fully appreciated in the context KIR2DS2-Ig fusion protein to HLA-Cw3 transfectants, whereas binding by KIR2DL2 and KIR2DL3 fusion proteins was measof binding of activating KIR to natural ligand is the importance of raft formation and the generation of immunological urable. These studies are supported by plasmon surface resonance measurements using soluble recombinant KIR and synapses. Their importance has been shown dramatically in the case of T cell activation (23) (24) (25) (26) and there is evidence that similar processes are likely to occur with NK cell receptors interacting with their cellular ligands (20, 27) . It remains to be determined whether in the context of an immunological synapse the activating KIR2DS2 is more readily activated by natural ligand through mechanisms appreciated for T cell activation, such as serial triggering (28), co-stimulatory thresholds (29) and avidity (29,30).
In conclusion, these studies show that the activating KIR2DS2 can function in the presence of co-expressed inhibitory KIR2DL2 and/or KIR2DL3. It will now be important to determine if these results using CD158b mAb are applicable to responses to a natural ligand such as HLA-Cw3. A possible rationale for activating and inhibitory KIR recognizing the same HLA ligand to be co-expressed on the same NK cell is that when HLA concentrations on target cells are below that capable of inhibiting NK cell function there is a fail-safe mechanism for activating NK cells if no other NK cell-activating receptors or target cell ligands to activate those receptors are present. Data are presented as percent maximum response, calculated from cytotoxic units as described in Methods. The ratio of effector to P815 target cells was 1:1. (B) Cytotoxicity of NK cell line A was stimulated by CD158b (DX27) mAb at the dilutions indicated. Cytotoxicity is expressed as percent specific lysis, and the mean and SD of triplicate cultures is given. The background lysis of NK cells without mAb was 5%, which is the point of intersection of the x-axis with the y-axis. The ratio of effector to P815 target cells was 2:1. (C) NK cells from line C were stimulated with dilutions of CD158b (GL183) mAb and cytotoxicity calculated as cytotoxic units is presented as percent maximum response (j). The ratio of effector to P815 target cells was 2:1.
